Key facts
- This page summarizes Sven Dethlefs's Form 4 filing for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA).
- 7 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 07 Mar 2023, 15:04.
Sven Dethlefs - 03 Mar 2023 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
- Reporting relationship
- EVP, North America Commercial
- Issuer ticker
- TEVA
- Reported as of
- 03 Mar 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 07 Mar 2023, 15:04:11 UTC
- Prior SEC filing
- 02 Mar 2023
- Next SEC filing
- 08 Mar 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Dov Bergwerk as attorney-in-fact for Sven Dethlefs
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Sven Dethlefs filed Form 4 for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) on 07 Mar 2023.
Change
- Previous filing in this sequence was filed on 02 Mar 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TEVA
transaction
Ordinary Shares
Options Exercise
- Transaction value
- Shares
- +13,931
- Change %
- +8.4%
- Price
- Shares after
- 179,312
- Date
- 04 Mar 2023
- Ownership
- Direct
- Footnotes
- F1, F2
TEVA
transaction
Ordinary Shares
Options Exercise
- Transaction value
- Shares
- +38,538
- Change %
- +21%
- Price
- Shares after
- 217,850
- Date
- 04 Mar 2023
- Ownership
- Direct
- Footnotes
- F1, F2
TEVA
transaction
Ordinary Shares
Options Exercise
- Transaction value
- Shares
- +24,952
- Change %
- +11%
- Price
- Shares after
- 242,802
- Date
- 05 Mar 2023
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TEVA
transaction
Derivative
Restricted Share Units
Award
- Transaction value
- $0
- Shares
- +99,601
- Change %
- Price
- $0.000000
- Shares after
- 99,601
- Date
- 03 Mar 2023
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 99,601
- Exercise price
- Footnotes
- F1, F2, F3
TEVA
transaction
Derivative
Restricted Share Units
Options Exercise
- Transaction value
- $0
- Shares
- -13,931
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 04 Mar 2023
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 13,931
- Exercise price
- Footnotes
- F1, F2, F4
TEVA
transaction
Derivative
Restricted Share Units
Options Exercise
- Transaction value
- $0
- Shares
- -38,538
- Change %
- -25%
- Price
- $0.000000
- Shares after
- 115,617
- Date
- 04 Mar 2023
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 38,538
- Exercise price
- Footnotes
- F1, F2, F5
TEVA
transaction
Derivative
Restricted Share Units
Options Exercise
- Transaction value
- $0
- Shares
- -24,952
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 49,905
- Date
- 05 Mar 2023
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 24,952
- Exercise price
- Footnotes
- F1, F2, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Footnote F2
Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
Footnote F3
Restricted share units were granted on March 3, 2023, with 24,900 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 24,901 vesting on March 3, 2027.
Footnote F4
Restricted share units were granted on March 4, 2019, with 13,930 vested on each of March 4, 2021 and March 4, 2022, and 13,931 vested on March 4, 2023.
Footnote F5
Restricted share units were granted on March 4, 2022, with 33,538 vested on March 4, 2023, 33,538 vesting on each of March 4, 2024 and March 4, 2025, and 38,541 vesting on March 4, 2026.
Footnote F6
Restricted share units were granted on March 5, 2021, with 24,952 vested on each of March 5, 2022, March 5, 2023 and March 5, 2024, and 24,953 vesting on March 5, 2025.